Showing 1 - 3 results of 3 for search 'Jason T. Hindman', query time: 0.01s Refine Results
  1. 1
    Efficacy and safety of B/F/TAF in treatment-naïve and virologically suppressed people with HIV ≥ 50 years of age: integrated analysis from six phase 3 clinical trials

    Efficacy and safety of B/F/TAF in treatment-naïve and virologically suppressed people with HIV ≥ 50 years of age: integrated analysis from six phase 3 clinical trials by Cissy M. Kityo, Samir K. Gupta, Princy N. Kumar, Amy R. Weinberg, Bhumi Gandhi-Patel, Hui Liu, Jason T. Hindman, Jürgen K. Rockstroh

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Long-term metabolic changes with bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir-containing regimens for HIV

    Long-term metabolic changes with bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir-containing regimens for HIV by Eric S. Daar, Chloe Orkin, Paul E. Sax, Debbie Hagins, Anton Pozniak, Kimberly Workowski, Cynthia Brinson, Juan Manuel Tiraboschi, Hui Liu, Chris Deaton, Cal Cohen, Sharline Madera, Jason T. Hindman, Moti Ramgopal

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) After A Viremic Event: A Pooled Analysis of Studies in People with HIV

    Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) After A Viremic Event: A Pooled Analysis of Studies in People with HIV by Anton Pozniak, Chloe Orkin, Yazdan Yazdanpanah, Axel Baumgarten, Karam Mounzer, Michelle L. D’Antoni, Hailin Huang, Hui Liu, Kristen Andreatta, Laurie A. VanderVeen, Christian Callebaut, Jason T. Hindman, José R. Arribas

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: